Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards

Clinical Microbiology and Infection

Volumn 12, Issue 8, 2006, Pages 738-744

  Berthelot, Philippe ^a   Loulergue, P ^a   Raberin, H ^a   Turco, M ^a   Mounier, C ^a   Tran Manh Sung, R ^a   Lucht, F ^a   Pozzetto, B ^a   Guyotat, D ^a  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

Author keywords

Aspergillus fumigatus; Building work; Environmental surveillance; Haematology patients; Hospital acquired infection; Pulmonary aspergillosis

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENVIRONMENTAL MONITORING; FRANCE; HEALTH PROGRAM; HEALTH SURVEY; HEMATOLOGY; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; LUNG ASPERGILLOSIS; PRIORITY JOURNAL; PROTECTIVE CLOTHING; RANK SUM TEST; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL SIGNIFICANCE; WARD;

EID: 33745589241     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01499.x     Document Type: Article

References (15)

1. Stevens DA, Kan VL, Judson MA et al. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 696-709.
2. Mahieu LM, De Dooy JJ, Van Laer FA, Jansens H, Ieven MM. A prospective study on factors influencing aspergillus spore load in the air during renovation works in a neonatal intensive care unit. J Hosp Infect 2000; 45: 191-197.
3. Panagopoulou P, Filioti J, Petrikkos G et al. Environmental surveillance of filamentous fungi in three tertiary care hospitals in Greece. J Hosp Infect 2002; 52: 185-191.
4. Tablan OC, Anderson LJ, Besser R et al. Guidelines for preventing health-care-associated pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53: 1-36.
5. Nicolle MC, Lebeau B, Perraud M et al. Surveillance de l'environnement fongique en hématologie: Analyse des pratiques de neuf centres hospitaliers et élaboration d'un protocole commun. J Mycol Med 2002; 12: 12-20.
6. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and haematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.
7. Bocquet P, Aggoune M, Aussant M, Rykner G, Brucker G. Aspergillose invasive nosocomiale et travaux hospitaliers: Recommandations. Paris: Doin, 1993.
8. Alberti C, Bouakline A, Ribaud P et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in hematology patients. J Hosp Infect 2001; 48: 198-206.
9. Nolard N. Links between risks of aspergillosis and environmental contamination. Review of the literature. Path Biol 1994; 42: 706-710.
10. Loo VG, Bertrand C, Dixon C et al. Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol 1996; 17: 360-364.
11. Hahn T, Cummings M, Michalek AM, Lipman BJ, Segal BH, McCarthy PL. Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies. Infect Control Hosp Epidemiol 2002; 23: 525-531.
12. CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR 2000; 49: 1-128.
13. Bocquet P, Patris S, Dumartin C, Gottot S, Rykner G, Brucker G. The epidemiological surveillance network for nosocomial invasive aspergillosis of the Assistance Publique-Hôpitaux de Paris. Ann Med Intern 1995; 146: 79-83.
14. Raad I, Hanna H, Osting C et al. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol 2002; 23: 41-43.
15. Anonymous. Consensus conference: Preventing the risk of Aspergillus infection in immunocompromised patients. Bull Cancer 2001; 88: 589-600.